Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livermore

Showing results (151-160 of 963) with videos related to

Pageof 97
Sort By:
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Interactions of meropenem with class I chromosomal beta-lactamasesY J Yang, D M Livermore
Journal of Bacteriology|December 1, 1974
Lipids of the Spirochaetales: comparison of the lipids of several members of the genera Spirochaeta, Treponema, and LeptospiraB P Livermore, R C Johnson
The Journal of Antimicrobial Chemotherapy|May 1, 1994
In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanismsH Y Chen, D M Livermore
Antimicrobial Agents and Chemotherapy|October 7, 2000
Are SHV beta-lactamases universal in Klebsiella pneumoniae?G S Babini, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Quality of antimicrobial susceptibility testing in the UK: a Pseudomonas aeruginosa survey revisitedD M Livermore, H Y Chen
Antimicrobial Agents and Chemotherapy|September 1, 1988
Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganiiY J Yang, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 23, 2001
Detection of beta-lactamase-mediated resistanceD M Livermore, D F Brown
Antimicrobial Agents and Chemotherapy|January 1, 1986
Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolatesD M Livermore, C S Jones
Antimicrobial Agents and Chemotherapy|September 1, 1992
Effects of CO2 and pH on inhibition of TEM-1 and other beta-lactamases by penicillanic acid sulfonesD M Livermore, J E Corkill
Antimicrobial Agents and Chemotherapy|May 1, 1991
Invalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to beta-lactam antibioticsD M Livermore, K W Davy
Pageof 97

Showing results (151-160 of 963) with videos related to

Sort By:
Pageof 97
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Interactions of meropenem with class I chromosomal beta-lactamasesY J Yang, D M Livermore
Journal of Bacteriology|December 1, 1974
Lipids of the Spirochaetales: comparison of the lipids of several members of the genera Spirochaeta, Treponema, and LeptospiraB P Livermore, R C Johnson
The Journal of Antimicrobial Chemotherapy|May 1, 1994
In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanismsH Y Chen, D M Livermore
Antimicrobial Agents and Chemotherapy|October 7, 2000
Are SHV beta-lactamases universal in Klebsiella pneumoniae?G S Babini, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Quality of antimicrobial susceptibility testing in the UK: a Pseudomonas aeruginosa survey revisitedD M Livermore, H Y Chen
Antimicrobial Agents and Chemotherapy|September 1, 1988
Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganiiY J Yang, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 23, 2001
Detection of beta-lactamase-mediated resistanceD M Livermore, D F Brown
Antimicrobial Agents and Chemotherapy|January 1, 1986
Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolatesD M Livermore, C S Jones
Antimicrobial Agents and Chemotherapy|September 1, 1992
Effects of CO2 and pH on inhibition of TEM-1 and other beta-lactamases by penicillanic acid sulfonesD M Livermore, J E Corkill
Antimicrobial Agents and Chemotherapy|May 1, 1991
Invalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to beta-lactam antibioticsD M Livermore, K W Davy
Pageof 97